PNC Financial Services Group’s Aardvark Therapeutics AARD Stock Holding History
Bought
Maintained
Sold
Other funds holding AARD
PNC Financial Services Group's AARD Position: Q3 2026 in Review
PNC Financial Services Group reduced its Aardvark Therapeutics (AARD) stake by 1.4% in Q3 2026, selling an estimated $31 and leaving 344 shares worth $1.81K. The position accounts for ﹤0.01% of the portfolio, ranked #4861.
PNC Financial Services Group first reported a position in AARD in Q3 2025 and has held it in 4 quarters since. The position peaked at $2.01K in Q2 2026. 76 funds tracked by Wall St. Rank hold AARD as of Q3 2026.
- PNC Financial Services Group held 344 shares of Aardvark Therapeutics worth $1.81K as of Q3 2026.
- PNC Financial Services Group sold 5 Aardvark Therapeutics shares in Q3 2026, an estimated $31.
- Aardvark Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4861 holding.
- PNC Financial Services Group first reported a position in Aardvark Therapeutics in Q3 2025 and has held it in 4 quarters since.
- PNC Financial Services Group's Aardvark Therapeutics position peaked at $2.01K in Q2 2026.
- 76 funds tracked by Wall St. Rank held Aardvark Therapeutics as of Q3 2026.
Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.